English

New Anticancer Treatment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 forms  
New Anticancer Treatment
Description

New Anticancer Treatment

First Treatment Regimen:
Description

The patient has received new or additional anticancer treatment for NSCLC since discontinuing study drug. Record treatment and start date:

Data type

text

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0007131
Start Date
Description

Anticancer Treatment Start Date

Data type

date

Alias
UMLS CUI [1]
C3173309
Back to the top of the page

Similar models

New Anticancer Treatment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
New Anticancer Treatment
New Anticancer Treatment for NSCLC
Item
First Treatment Regimen:
text
C0087111 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
Anticancer Treatment Start Date
Item
Start Date
date
C3173309 (UMLS CUI [1])
Back to the top of the page